1
Return

Ultra-sensitive urine DNA methylation test enables early and accurate detection of bladder cancer

delete2026-06-22
delete0
PRE
AI
Z
Zhichao Tong
T
Tianxi Yu
Z
Zhilong Li
F
Fengming Zhang
Q
Qing Shi
J
Jiaxi Peng
Y
Yubo Zhao
Y
Yaowei Li
Z
Zhihui Xiu
Z
Zhishuai Zhang
B
Benchi Li
W
Weijia Jiang
H
Hongjian Song
Z
Zongzheng Yang
H
Haonan Li
P
Pengyu Guo
D
Dayong Hou
Z
Zhihao Yin
Z
Ziyi Liu
Q
Qi Liu
J
Jianwei Wang
P
Peng Zhang
P
Peng Dai
Y
Yuying Wang
D
Di Wang
H
Hang Su *
Z
Ziqi Wang *
DOI:10.1080/17501911.2026.2688972delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Early and accurate detection of bladder cancer (BCa), particularly low-grade and early-stage disease, remains challenging because current diagnostic methods are either invasive or insufficiently sensitive. We aimed to develop a noninvasive urine DNA methylation assay for BCa detection and postoperative monitoring. Integrative methylation profiling across institutional and public cohorts identified PENK and NKPD1 as urothelial carcinoma-associated hypermethylation markers. A bisulfite-free methylation-sensitive restriction enzyme quantitative polymerase chain reaction (MSRE-qPCR) assay was developed using urine sediment DNA. Diagnostic performance was evaluated in a case-control cohort of 606 urine samples, including 340 pathologically confirmed BCa cases. The dual-marker assay achieved areas under the curve (AUCs) of 92.52% and 93.00% in the training and validation cohorts, respectively. Sensitivity reached 87.74%, with specificity of 92.31% against benign urological diseases and 83.05% against non-urothelial malignancies. The assay outperformed urine cytology in low-grade tumors and provided complementary diagnostic value when combined with cytology. Postoperative methylation signals significantly decreased after tumor resection (p < 0.001). This bisulfite-free urine MSRE-qPCR assay provides a simple and scalable approach for noninvasive BCa detection and surveillance, with strong performance in early-stage and low-grade disease. Further prospective multicenter validation is warranted.
Keywords:
Urinary bladder neoplasms
DNA methylation
urine biomarkers
early detection of cancer
noninvasive diagnosis

Journal

Epigenomics cover
Epigenomics
IF:
2.6
Papers:
1.8K
Citations:
3.4K

Organization

H
Harbin Medical University
Scholars:
2.9W
Papers: 1.3W
Citations: 1.6W
B
BGI Genomics
Scholars:
114
Papers: 33
Citations: 573
Cited Papers

Cited Papers

Citing Papers

Citing Papers